New diabetes treatments can be hard to keep track of. Here we take a look at some of the newer treatments and trials for diabetes.
Type 2 diabetes European Commission has granted marketing authorization in Europe. For Sanofi’s Suliqua, a once-daily injection for the treatment of adults with Type 2
Researchers in an international study have uncovered new genetic evidence of how the benefits of the world’s most commonly used Type 2 diabetes drug may
In December AstraZeneca announced an agreement under which it will acquire the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance for an initial
A Chinese research study of diabetes patients with coronary heart disease concluded that metformin is more effective than glipizide in reducing the risk of major
Eli Lilly & Co says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken drugs in three just-concluded Phase III studies. According to
Metformin is the aspirin of the diabetes world, an almost-wonder drug that proves itself again and again the longer it’s around. This time, a new
GPs are being urged to ramp up diabetes treatment within just three months if they do not reach their glycaemic goals on metformin alone, under
According to new guidelines from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) it may be better for
The latest clinical guidelines for treating type 2 diabetes from the American College of Physicians (ACP) indicate that when diet, exercise, and weight loss fail
